0000-0001-5727-0034 About
I, am Altaf Ahmad Shah, currently working as a Senior Research Fellow at ICMR, India.I have joined the department of bioengineering at integral university, Lucknow. My research is focused on the computational design and development of anti-tumor angiogenic drug/s using phytochemicals that may have synergetic potential to inhibit tumor growth by hijacking and aborting the blood supply. I have more than three years of research experience in the field of computational drug design and development. I have two international publications and another one is in the queue that will be published soon, InshaAllah.
Employment
-
Integral University Senior Research Fellow2021 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (11)
- Tumor Angiogenesis and EGFR-Mutated Cancers: Structural Insights, Mutation Dynamics, and Innovative Therapeutic Strategies Save
- Correction to: In Silico Investigation against Inhibitors of Alpha-Amylase Using Structure-based Screening, Molecular Docking, and Molecular Simulations Studies (Cell Biochemistry and Biophysics, (2024), 10.1007/s12013-024-01403-9) Save
- In Silico Investigation against Inhibitors of Alpha-Amylase Using Structure-based Screening, Molecular Docking, and Molecular Simulations Studies Save
- Molecular modeling, dynamic simulation, and metabolic reactivity studies of quinazoline derivatives to investigate their anti-angiogenic potential by targeting wild EGFRwt and mutant EGFRT790M receptor tyrosine kinases Save
- Polydatin inhibits histone deacetylase 1 and shows an anti-angiogenic action in head and neck squamous cell carcinoma Save
- Structure-based Virtual Screening, Molecular Docking, Molecular Dynamics Simulation, and Metabolic Reactivity Studies of Quinazoline Derivatives for their Anti-EGFR Activity Against Tumor Angiogenesis Save
- Design and Modeling of 4-Anilinoquinazoline Derivatives as Small Molecule Inhibitors of T790M/C797S EGFR Mutations to Abandon the Phenomenon of Tumor Angiogenesis Save
- INDOLINONE DERIVATIVES AS PROMISMING ANTI VEGFR-2 AGENTS TARGETING TUMOR ANGIOGENESIS: A COMPREHENSIVE IN SILICO CASE STUDY. Save
- Design and Modeling of 4-Anilinoquinazoline Derivatives as Small Molecule Inhibitors of T790M/C797S EGFR Mutations to Abandon the Phenomenon of Tumor Angiogenesis Save
- Tumor Angiogenesis and VEGFR-2: Mechanism, Pathways and Current Biological Therapeutic Interventions Save